Automation Upgrade at Influenza Vaccine Manufacturing Facility
This £20m retrofit and phased expansion of an existing biotechnology facility aimed to reduce costs by increasing efficiency, increasing yield, reducing waste, and increasing process automation – including multiple interfaces with manufacturing.
- Liverpool, North West England, UK
- ISPE 2013 Facility of the Year Award for Equipment Innovation
- 'Facility of the Year' Award from the IPSE